News – Page 1163 – Endpoints News

Tesaro makes its case for a clean sweep with niraparib - and shares soar again

9 years ago

Kite touts 12-month remission data from tiny CAR-T study; Ironwood exec dies in bike accident

9 years ago

Thumbs Up/Thumbs Down: Major insurer delivers a bad blow to Duchenne families

9 years ago

Clovis shares tank after investors size up the disappointing data on rucaparib

9 years ago

Updated Incyte combo data for epacadostat/Keytruda look promising

9 years ago

Lethal experimental cancer drug from Hanmi, Boehringer killed three patients — report

9 years ago

Pfizer plots a big move (but it's not going very far)

9 years ago

Medicxi launches a diabetes upstart with $11M; Arrowhead partners on hep B; Immunotherapy startup gains $12.2M round

9 years ago

Reuters probe spotlights a conflict of interest between biotech investor F-Prime and giant Fidelity

9 years ago

Teva hands Celltrion $160M to grab US rights on two biosimilars of Roche blockbusters

9 years ago

Pilot project provides a snapshot of effectiveness of Pfizer’s PARP contender talazoparib

9 years ago

Feds help NewLink, Merck out with some added cash for Ebola vaccine

9 years ago

Alnylam shares crater after trial deaths force investigators to scrap PhIII RNAi drug

9 years ago

Can We Conquer All Diseases By The End Of The Century? An Interview with Chan Zuckerberg's Cori Bargmann.

9 years ago

UK startup tackles hot neoantigen field in cancer drugs

9 years ago

Biotech billionaire backs a food allergy/nutrition startup; Editas recruits a CMO

9 years ago

André Choulika on gene editing: "If you marry yourself to a technology, you're doomed."

9 years ago

AstraZeneca jettisons another drug, this time grabbing $30M for out-licensing deal

9 years ago

Hold the applause: Big Pharma has little to brag about regarding 2016 R&D productivity

9 years ago

Novartis unveils a new global R&D structure, creating centers in Cambridge, MA and Basel

9 years ago

Novartis is uprooting another research group in ongoing global reorganization

9 years ago

Samsung BioEpis pitches Herceptin biosimilar as parent company hunts $2B IPO; Chiasma CEO is out

9 years ago

Hustling to capture top frontline NSCLC status, Roche scores a ‘breakthrough’ on Alecensa

9 years ago

Amgen joins a marquee list of partners jumping on Nuevolution’s discovery platform

9 years ago

First page Previous page 1160 1161 116211631164 1165 1166 Next page Last page